Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. (Record no. 17507422)

MARC details
000 -LEADER
fixed length control field 02402 a2200721 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515093422.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200803s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1476-5551
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/sj.leu.2405014
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name de Lima, M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20080326
245 00 - TITLE STATEMENT
Title Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Leukemia
Date of publication, distribution, etc. Feb 2008
300 ## - PHYSICAL DESCRIPTION
Extent 258-64 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aminoglycosides
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antigens, CD
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antigens, Differentiation, Myelomonocytic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gemtuzumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Graft Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hematopoietic Stem Cell Transplantation
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Myeloid
General subdivision mortality
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melphalan
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Myelodysplastic Syndromes
General subdivision mortality
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Remission Induction
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sialic Acid Binding Ig-like Lectin 3
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Transplantation, Homologous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vidarabine
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Champlin, R E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thall, P F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wang, X
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Martin, T G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cook, J D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McCormick, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Qazilbash, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kebriaei, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Couriel, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shpall, E J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Khouri, I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Anderlini, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hosing, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chan, K W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Andersson, B S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Patah, P A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Caldera, Z
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jabbour, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Giralt, S
773 0# - HOST ITEM ENTRY
Title Leukemia
Related parts vol. 22
-- no. 2
-- p. 258-64
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/sj.leu.2405014">https://doi.org/10.1038/sj.leu.2405014</a>
Public note Available from publisher's website

No items available.